Diversifying Clinical Trials: A Global Initiative With Local Roots


Increasing diversity in clinical trials (DiCT) is imperative to improve the health of populations around the world. Everyone has the right to achieve optimal health outcomes — that’s the core of what health equity means. Without including representative populations in clinical trials, diverse groups are unable to participate in the development of critical, often life-saving, therapies — exacerbating inequities and creating new ones.

Tomorrow's Innovators: Kwame Sarpong


Our own Kwame Sarpong discusses his journey to BMS – from growing up in Ghana to his studies at Howard University.

Read his story and the advice he has for Black talent interested in the biopharma field.

Q. How did you get started in the biopharma industry?

Encouraging Recruitment of Diverse Talent in the Biopharma Industry


By Tunde Bello

I am a Black British man with an African name living in the United States. There are many times when I feel that I alone represent a whole group of people. I felt the weight of that responsibility every day when I started my career in drug development because in most meetings, I was the only person of color.

The Bristol Myers Squibb Foundation Diversity in Clinical Trials Career Development Program Announces First Group of Physicians to Be Trained

52 physicians from across the U.S. selected for the inaugural cohort of the five-year, $100 million initiative
Press Release

PRINCETON, N.J., October 22, 2021 /3BL Media/ - The Bristol Myers Squibb Foundation (BMSF), together with its partners, National Medical Fellowships (NMF) and the American Association for Cancer Research (AACR), today announced th

OLA and PRIDE Alliance PBRGs teamed up to host an empowering storytelling forum

Multimedia with summary

Saliendo! Our OLA and PRIDE Alliance PBRGs teamed up to host an empowering storytelling forum featuring BristolMyersSquibb employees reflecting on their coming out journeys within Hispanic & LatinX communities.

Celebrating the Science That Transforms Patients' Lives


By Samit Hirawat, M.D., Executive Vice President, Chief Medical Officer, Global Drug Development

Team BMS Moves for Minutes to Benefit Special Olympics

$1 million donation to Special Olympics supports mission of building a more inclusive world

Bristol Myers Squibb will donate $1 million to Special Olympics as part of the company’s global workforce charity event, BMS for Community. During the event, employees, their families and patients came together to move for minutes in any way that felt most comfortable, with the goal of supporting Special Olympics in its efforts to build a world celebrating people of all abilities.

And there was no shortage of minutes moved.

Bristol Myers Squibb Matches Employee-led Donations to Community

Multimedia with summary

Last year, our employee-led People & Business Resource Groups identified impactful organizations fighting disparities and discrimination. When U.S. and Puerto Rico-based employees donate to these selected groups, the Bristol Myers Squibb Foundation double-matches their gifts. Learn more about this special Employee Giving program.

Country 2 Country 4 Cancer (C2C4C) Event

Multimedia with summary

More than 150 colleagues from 14 EU countries just finished cycling 3,000 km in our Country 2 Country 4 Cancer (C2C4C) event to raise awareness and much-needed donations for cancer research. It’s more than a bike ride — together, as one global BMS family, it’s part of our long-standing commitment to cancer research and our patients.


Subscribe to NYSE: BMY